Login to Your Account

Targacept Ends GSK Alliance, Regains NNR Program Rights

By Marie Powers

Friday, March 4, 2011
Following the decision last year by GlaxoSmithKline plc (GSK) to dial down its neuroscience research activities, Targacept Inc. has yanked its strategic alliance with GSK, effective May 29.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription